VEGFR TKI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VEGFR TKI, covering 2021-04-26 to 2021-04-26. Get the full timeline:
Most recent: Clinical Trial Update: A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer [Phase 2]